PDF) Participación del Factor de Necrosis Tumoral Alfa en la Proliferación de carcinomas mamarios.
FACTOR NUCLEAR κB (NF-κB): SIGNALOSOMA Y SU IMPORTANCIA EN ENFERMEDADES INFLAMATORIAS Y CÁNCER
Tumor necrosis factor - Wikipedia
Média e desvio padrão de tumor necrosis factor-alpha (TNF-alfa, fator... | Download Scientific Diagram
Nuclear Factor κB Signaling in Atherogenesis | Arteriosclerosis, Thrombosis, and Vascular Biology
Nuclear Factor κB Signaling in Atherogenesis | Arteriosclerosis, Thrombosis, and Vascular Biology
La regulación del factor de transcripción NF-κB. Un mediador molecular en el proceso inflamatorio
Estudio del efecto del factor de Necrosis tumoral -alfa sobre las neuronas dopaminérgicas de la substantia nigra en relación a
Factor de necrosis tumoral (TNF): estructura, mecanismo de acción, función
La regulación del factor de transcripción NF-κB. Un mediador molecular en el proceso inflamatorio
Inflammation and tumor progression: signaling pathways and targeted intervention | Signal Transduction and Targeted Therapy
Participación del factor de necrosis tumoral-α en la aterosclerosis
Nuclear Factor κB Signaling in Atherogenesis | Arteriosclerosis, Thrombosis, and Vascular Biology
Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammation - ScienceDirect
Factor De Necrosis Tumoral (Fnt)
Frontiers | Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer
Participación del factor de necrosis tumoral-α en la aterosclerosis
Frontiers | The Role of Tumor Necrosis Factor in Manipulating the Immunological Response of Tumor Microenvironment
Metabolic Messengers: tumour necrosis factor | Nature Metabolism
Life, death, and autophagy in cancer: NF-κB turns up everywhere | Cell Death & Disease
Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin β receptor and the tumor necrosis factor receptor - ScienceDirect
NF-κB - Wikipedia, la enciclopedia libre
Cancers | Free Full-Text | Tumor Necrosis Factor Receptor 2 (TNFR2): An Emerging Target in Cancer Therapy
Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin β receptor and the tumor necrosis factor receptor | Clínica e Investigación en Arteriosclerosis
